|
|
|
|
|
|
 |
Director of Workforce
Development and Operations
San
Diego State University
|
Dr. Sevier has 23 years experience in biotechnology starting with BioSciences Laboratories in 1976 developing clinical laboratory testing systems. He was one of the earliest Hybritech Incorporated scientists and was involved in product development, product approval and technical education of both customers and employees. Prior to joining San Diego State University and the CSUPERB group, he was a consultant helping bring new products to market and developing data handling systems for Northern California biotechnology companies.
Dr. Sevier is a member of the Hybritech President’s Club, a recipient of the Hybritech Team-Excellence Quality award and instrumental in training more than 700 employees in management, quality and team techniques. He presently sits on the Workforce and Education Committee of BIOCOM/sandiego.
Education
B.A., Microbiology, University of California, Riverside, 1967.
M.S., Biological Chemistry, San Diego State University, 1969.
Ph.D., Biochemistry, University of California, Riverside, 1973.
Post-doctoral Fellow, Scripps Clinic and Research Foundation, 1976.
Experience
Research Scientist, BioScience Laboratories, Van Nuys, CA, 1979.
Manager of Customer and Technical Services, Hybritech Incorporated, San Diego, CA, 1979-1995.
Director of Customer Services, Tosoh Medics, Foster City, CA, 1996.
President, Sevier & Associates, Half Moon Bay, CA, 1996-2000.
Director, Workforce Development, California State University Program for Education and Research in Biotechnology (CSUPERB), San Diego, CA, 2000-present.
Bibliography
Sevier E D
Producing a quality product.
Biochem Mol Biol Ed. In press 2002Sevier E D, Dahms A S
The role of foreign worker scientists in the US biotechnology industry.
Nature Biotechnology. 2002 Sep 01 (20), 955-6
Sevier E D
Monoclonal antibodies: expanded potential for labeled antibody ligand assays.
Am J Med Technol. 1982 Aug;48(8):651-3.
Hofman F M, Kanesberg B, Smith D, Garrison D, Sevier E D
Stability of T- and B-cell numbers in human peripheral blood.
Am J Clin Pathol. 1982 Jun;77(6):710-3.
Shimizu S Y, Present W A, Sevier E D, Wang R, Saunders R L RL
Chorigonadotropin measured by use of monoclonal antibodies in a two-site immunoradiometric assay.
Clin Chem. 1982 Mar;28(3):546-7.
Sevier E D , David G S, Martinis J, Desmond W J, Bartholomew R M, Wang R
Monoclonal antibodies in clinical immunology.
Clin Chem. 1981 Nov;27(11):1797-806.
David G S, Present W, Martinis J, Wang R, Bartholomew R
Monoclonal antibodies in the detection of hepatitis infection.
Med Lab Sci. 1981 Oct;38(4):341-8.
David G S, Wang R, Bartholomew R, Sevier E D, Adams T H
The hybridoma-an immunochemical laser.
Clin Chem. 1981 Sep;27(9):1580-5.
Sevier E D, Shannon L M
Plant glycoprotein biosynthesis. Uridine diphosphate N-acetyl-glucosaminyltransferase from horseradish root.
Biochim Biophys Acta. 1977 Apr 27;497(2):578-85.
Wang R, Sevier E D, Reisfeld R A, David G S
Semi-automatic solid-phase radioimmunoassay for carcinoembryonic antigen.
J Immunol Methods. 1977;18(1-2):157-64.
Sevier E D
Sensitive, solid-phase assay of proteolytic activity.
Anal Biochem. 1976 Aug;74(2):592-6.
Sevier E D, Reisfeld R A
Semi-automatic solid-phase double-antibody radioimmunoassay for beta2-microglobulin.
Immunochemistry. 1976 Jan;13(1):35-7.
Wang R, Sevier E D, David G S, Reisfeld R A
An affinity adsorbent for the rapid purification of wheat germ agglutinin.
J Chromatogr. 1975 Nov 12;114(1):223-6.
Oh S K, Pellegrino M A, Ferrone S, Sevier E D, Reisfeld R A
Soluble HL-A antigens in serum. I. Isolation and purification.
Eur J Immunol. 1975 Mar;5(3):161-6.
McCroskey R P, Griswold W R, Sokoloff R L, Sevier E D, Lin S
Studies pertaining to the purification and properties of thymine 7-hydroxylase.
Biochim Bio